Recombinant Human CD164 Protein

Product Overview Description Recombinant Human CD164 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Asp24-Asp162. Purity > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC Accession Q04900 Target Symbol CD164 Synonyms MUC-24; Endolyn; MGC-24; Cd164; CD164; MGC-24v; sialomucin Species Human Expression System HEK293 Tag C-hFc Expression Range Asp24-Asp162 Mol. Weight The protein has a predicted MW of 41.2 kDa. Due to glycosylation, the protein migrates to 110-115 kDa based on Tris-Bis PAGE result. Form Lyophilized Formulation Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. Endotoxin Less than 1EU per ug by the LAL method. Storage Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Shipping Shipped at ambient temperature. Gene Background CD164 was found to play a role in many malignant diseases. CD164 was associated with clinical and pathological features of patients. High level of CD164 was related to the distant metastasis and vascular invasion of bladder cancer patients.CD164 was associated with the poor clinical outcomes of BC patients. Silencing of CD164 could inhibit the progression of tumors in vivo and in vitro, which may become an effective target in the treatment of bladder cancer.